GSK CONSUMER | AVANTI FEEDS | GSK CONSUMER/ AVANTI FEEDS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 39.1 | 14.8 | 264.0% | View Chart |
P/BV | x | 11.0 | 5.2 | 210.8% | View Chart |
Dividend Yield | % | 1.0 | 0.9 | 113.2% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
GSK CONSUMER Mar-19 |
AVANTI FEEDS Mar-19 |
GSK CONSUMER/ AVANTI FEEDS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 7,819 | 2,525 | 309.7% | |
Low | Rs | 5,832 | 306 | 1,905.8% | |
Sales per share (Unadj.) | Rs | 1,136.9 | 2,560.8 | 44.4% | |
Earnings per share (Unadj.) | Rs | 233.7 | 225.1 | 103.8% | |
Cash flow per share (Unadj.) | Rs | 248.1 | 251.4 | 98.7% | |
Dividends per share (Unadj.) | Rs | 105.00 | 4.00 | 2,625.0% | |
Dividend yield (eoy) | % | 1.5 | 0.3 | 544.4% | |
Book value per share (Unadj.) | Rs | 973.5 | 885.4 | 109.9% | |
Shares outstanding (eoy) | m | 42.06 | 13.62 | 308.8% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 6.0 | 0.6 | 1,086.1% | |
Avg P/E ratio | x | 29.2 | 6.3 | 464.6% | |
P/CF ratio (eoy) | x | 27.5 | 5.6 | 488.8% | |
Price / Book Value ratio | x | 7.0 | 1.6 | 438.6% | |
Dividend payout | % | 44.9 | 1.8 | 2,529.1% | |
Avg Mkt Cap | Rs m | 287,083 | 19,279 | 1,489.1% | |
No. of employees | `000 | 3.8 | 1.0 | 381.3% | |
Total wages/salary | Rs m | 6,446 | 1,003 | 642.6% | |
Avg. sales/employee | Rs Th | 12,440.2 | 34,601.0 | 36.0% | |
Avg. wages/employee | Rs Th | 1,677.0 | 995.2 | 168.5% | |
Avg. net profit/employee | Rs Th | 2,556.7 | 3,042.0 | 84.0% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 47,820 | 34,878 | 137.1% | |
Other income | Rs m | 4,326 | 538 | 803.6% | |
Total revenues | Rs m | 52,146 | 35,416 | 147.2% | |
Gross profit | Rs m | 11,410 | 4,073 | 280.2% | |
Depreciation | Rs m | 606 | 358 | 168.9% | |
Interest | Rs m | 8 | 26 | 29.7% | |
Profit before tax | Rs m | 15,123 | 4,226 | 357.8% | |
Minority Interest | Rs m | 0 | 3 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 52 | 0.0% | |
Tax | Rs m | 5,295 | 1,214 | 436.0% | |
Profit after tax | Rs m | 9,828 | 3,066 | 320.5% | |
Gross profit margin | % | 23.9 | 11.7 | 204.3% | |
Effective tax rate | % | 35.0 | 28.7 | 121.9% | |
Net profit margin | % | 20.6 | 8.8 | 233.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 52,674 | 11,795 | 446.6% | |
Current liabilities | Rs m | 18,140 | 2,199 | 824.7% | |
Net working cap to sales | % | 72.2 | 27.5 | 262.5% | |
Current ratio | x | 2.9 | 5.4 | 54.1% | |
Inventory Days | Days | 36 | 40 | 89.6% | |
Debtors Days | Days | 29 | 5 | 578.3% | |
Net fixed assets | Rs m | 4,798 | 3,330 | 144.1% | |
Share capital | Rs m | 421 | 136 | 308.8% | |
"Free" reserves | Rs m | 40,527 | 11,923 | 339.9% | |
Net worth | Rs m | 40,947 | 12,060 | 339.5% | |
Long term debt | Rs m | 0 | 11 | 0.0% | |
Total assets | Rs m | 60,681 | 16,148 | 375.8% | |
Interest coverage | x | 1,939.8 | 161.7 | 1,199.7% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.8 | 2.2 | 36.5% | |
Return on assets | % | 16.2 | 19.2 | 84.6% | |
Return on equity | % | 24.0 | 25.4 | 94.4% | |
Return on capital | % | 37.0 | 35.7 | 103.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 3,171 | 16 | 20,313.2% | |
Fx outflow | Rs m | 1,770 | 1,486 | 119.1% | |
Net fx | Rs m | 1,401 | -1,470 | -95.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 6,711 | 1,838 | 365.2% | |
From Investments | Rs m | -3,351 | -268 | 1,251.2% | |
From Financial Activity | Rs m | -3,768 | -1,058 | 356.2% | |
Net Cashflow | Rs m | -408 | 512 | -79.6% |
Indian Promoters | % | 0.0 | 44.2 | - | |
Foreign collaborators | % | 72.5 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.8 | 2.8 | 28.6% | |
FIIs | % | 12.0 | 3.2 | 375.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 14.8 | 0.0 | - | |
Shareholders | 26,457 | 8,560 | 309.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare GSK CONSUMER With: GOODRICKE VADILAL INDUSTRIES NESTLE RASOYA PROTEINS SANWARIA CONSUMER
Compare GSK CONSUMER With: TIGER BRANDS (S. Africa) COCA COLA (US) NESTLE (Switz.) AVI LTD. (S. Africa)
Indian share markets ended on a strong note on Tuesday. Benchmark indices extended gains after the Indian government fast-tracked emergency approvals for foreign produced Covid-19 vaccines.
For the quarter ended December 2020, AVANTI FEEDS has posted a net profit of Rs 869 m (up 47.2% YoY). Sales on the other hand came in at Rs 9 bn (down 0.8% YoY). Read on for a complete analysis of AVANTI FEEDS's quarterly results.
For the quarter ended June 2020, AVANTI FEEDS has posted a net profit of Rs 1 bn (up 14.1% YoY). Sales on the other hand came in at Rs 10 bn (down 12.6% YoY). Read on for a complete analysis of AVANTI FEEDS's quarterly results.
Does the company with one of the fastest-growing QSR chains in India have sound prospects?
For the quarter ended March 2020, AVANTI FEEDS has posted a net profit of Rs 987 m (up 29.2% YoY). Sales on the other hand came in at Rs 10 bn (up 20.7% YoY). Read on for a complete analysis of AVANTI FEEDS's quarterly results.
For the quarter ended December 2019, GSK CONSUMER has posted a net profit of Rs 3 bn (up 25.1% YoY). Sales on the other hand came in at Rs 12 bn (up 3.8% YoY). Read on for a complete analysis of GSK CONSUMER's quarterly results.
More Views on NewsAjit Dayal on how India's vaccine strategy will impact the markets.
Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.
This could take India to the position of 3rd largest economy.
In this video, I'll you what I think is the real reason behind yesterday's market crash.
In this video, I'll tell you the two reasons why the market fell on Monday and how you can prepare yourself for such events in the future.
More